Arcellx News - ACLX

Company Name	Stock Ticker Symbol	Market	Type
Arcellx Inc	ACLX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-1.62	-2.98%	52.82	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
54.54	52.54	54.94	52.82	54.44

more quote information »

Recent News

Date	Time	Source	Heading
4/04/2024	16:00	BW	Arcellx to Participate in the 23rd Annual Needham Virtual..
3/20/2024	16:00	BW	Arcellx to Participate at the H.C. Wainwright 2nd Annual..
3/07/2024	18:23	EDGAR2	Form 144 - Report of proposed sale of securities
2/29/2024	16:00	PRNUS	Arcellx to Participate at the TD Cowen 44th Annual Health..
2/28/2024	16:02	EDGAR2	Form 8-K - Current report
2/28/2024	16:00	PRNUS	Arcellx Provides Fourth Quarter and Year-End 2023 Financial..
2/14/2024	17:57	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/12/2024	19:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/09/2024	16:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/08/2024	21:41	EDGAR2	Form 144 - Report of proposed sale of securities
1/31/2024	16:19	EDGAR2	Form 8-K - Current report
1/08/2024	16:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/08/2024	16:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	20:24	EDGAR2	Form 144 - Report of proposed sale of securities
1/04/2024	20:23	EDGAR2	Form 144 - Report of proposed sale of securities
1/04/2024	19:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	19:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	16:22	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
12/28/2023	18:06	EDGAR2	Form 144 - Report of proposed sale of securities
12/28/2023	16:47	EDGAR2	Form 8-K - Current report
12/19/2023	16:43	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/18/2023	16:33	EDGAR2	Form 144 - Report of proposed sale of securities
12/18/2023	16:16	EDGAR2	Form SC 13D/A - General statement of acquisition of..
12/14/2023	17:52	EDGAR2	Form 144 - Report of proposed sale of securities
12/12/2023	07:37	EDGAR2	Form 8-K - Current report
12/08/2023	17:16	EDGAR2	Form 8-K - Current report
12/08/2023	16:00	PRNUS	Arcellx Announces Continued Robust Long-Term Responses from..
11/15/2023	08:30	DJN	Arcellx Shares Rise Premarket on Expanded Gilead..
11/15/2023	06:58	DJN	Gilead Invests Further in Arcellx, Extends Collaboration
11/15/2023	06:16	EDGAR2	Form 8-K - Current report
11/15/2023	06:00	BW	Kite and Arcellx Announce Expansion in Strategic Partnership
11/13/2023	16:05	EDGAR2	Form 8-K - Current report
11/13/2023	16:00	PRNUS	Arcellx Provides Third Quarter 2023 Financial Results and..
11/02/2023	09:13	EDGAR2	Form 8-K - Current report
11/02/2023	09:00	PRNUS	Arcellx Announces Oral Presentation for Its CART-ddBCMA..
10/26/2023	16:00	PRNUS	Arcellx to Participate in Two Upcoming Investor Conferences
8/14/2023	16:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	16:06	EDGAR2	Form 8-K - Current report
8/14/2023	16:00	PRNUS	Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1..
8/07/2023	16:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/04/2023	16:14	EDGAR2	Form 144 - Report of proposed sale of securities
7/21/2023	16:44	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
7/05/2023	20:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/03/2023	13:27	EDGAR2	Form 144 - Report of proposed sale of securities
6/20/2023	06:57	DJN	Arcellx Shares Drop After Patient Death Draws Clinical Hold..
6/19/2023	19:46	PRNUS	Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2..
5/08/2023	16:00	PRNUS	Arcellx Provides First Quarter Financial Results